Literature DB >> 25605146

Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients.

Farkhondeh Pouresmaeili1, S Jalil Hosseini, Farah Farzaneh, Arezoo Karimpour, Eznollah Azargashb, Mohammad Yaghoobi, Maryam Kamarehei.   

Abstract

BACKGROUND: The Prostate cancer is the 2nd most common cancer worldwide for males, and the 5th most common cancer overall, with an estimated 900,000 new cases diagnosed in 2008 (14% of the total in males and 7% of the total overall) aim of this study was to assess some of the most proposed environmental factors influencing the incidence of prostate cancer among Iranian men. Smoking, opioids, occupation and living location were considered as studied risk factors of the prostate cancer in this research.
MATERIAL AND METHODS: Two groups of affected men with prostate cancer and controls aged 50-75 years referred to medical clinics were subjects in this case-control study. Living and working place, smoking and drug consuming habits were assessed for any associations with prostate cancer.
RESULTS: The largest number, of patients, in order, belonged to Tehran, provincial capitals, major industrial cities, small towns and villages, respectively. The disease showed links with smoking and drugs with a significant difference between controls and patients (P value <0.0001).
CONCLUSIONS: Our recent evidence duplicates previously done researches confirming the serious adverse effects of smoking and drugs on the prostate cancer occurrence in Iranian men. Living place bearings some hazardous behaviors which increases the rate of diseases as well as advanced chance for associated cancers like prostate.

Entities:  

Mesh:

Year:  2014        PMID: 25605146     DOI: 10.7314/apjcp.2014.15.24.10603

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  1 in total

1.  A screening of growth inhibitory activity of Iranian medicinal plants on prostate cancer cell lines.

Authors:  Majid Asadi-Samani; Mahmoud Rafieian-Kopaei; Zahra Lorigooini; Hedayatollah Shirzad
Journal:  Biomedicine (Taipei)       Date:  2018-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.